Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril

American Journal of Hypertension

Volumn 11, Issue 9, 1998, Pages 1065-1073

  Bauduceau, Bernard ^a,f   Genès, Nathalie ^b   Chamontin, Bernard ^c   Vaur, Laurent ^b   Renault, Maguy ^d   Etienne, Sylvie ^b   Marre, Michel ^e  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b Laboratoires Roussel   (France)

^c CHU PURPAN   (France)

^d HMR France   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f HÔPITAL D'INSTRUCTION DES ARMÉES BÉGIN   (France)

Author keywords

Ambulatory blood pressure monitoring; Angiotensin converting enzyme inhibitor; Diabetes mellitus; Urinary albumin excretion

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANDOLAPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SPHYGMOMANOMETER; URINARY EXCRETION;

EID: 0032169111     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00118-6     Document Type: Article

References (41)

1. 1. Tarnow L, Rossing P, Gall M, et al: Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 1994;17:1247-1251.
2. 2. The Hypertension in Diabetes Study Group: Hypertension in diabetes study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993;11:309-317.
3. 3. The Hypertension in Diabetes Study Group: Hypertension in diabetes study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patient. J Hypertens 1993;11:319-325.
4. 4. Parving HH, Oxenboll B, Svendsen PA, et al: Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol 1982;100:550-555.
5. 5. Viberti GC, Hill RD, Jarret RD, et al: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i:1430-1432.
6. 6. Parving HH, Jensen HE, Mogensen CE, et al: Increased urinary albumin excretion in benign essential hypertension. Lancet 1974;i:231-237.
7. 7. Losito A, Fortunati F, Zampi I, et al: Impaired renal functional reserve and albuminuria in essential hypertension. Br Med J 1988;296:1562-1564.
8. 8. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-360.
9. 9. Neil A, Hawkins M, Potok M, et al: A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993;16: 996-1003.
10. 10. Redon J, Liao Y, Lozano JV, et al : Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens 1994;7:801-807.
11. 11. Agewall S, Persson B, Samuelsson O, on behalf of The Risk Factor Intervention Study Group: Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993;11:461-469.
12. 12. Ljungman S, Wikstrand J, Hartford M, et al: Urinary albumin excretion. A predictor of risk for cardiovascular disease. A prospective 10-year follow-up of middle-aged non diabetic normal and hypertensive men. Am J Hypertens 1996;9:770-778.
13. 13. Parving HH: Microalbuminuria in essential hypertension and diabetes mellitus. J Hypertens 1996;14(suppl 2):S89-S94.
14. 14. Ravid M, Savin H, Jutrin I, et al: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-581.
15. 15. Pickering TG, James GD, Boddie C, et al: How common is white coat hypertension? JAMA 1988;259:225-228.
16. 16. Schrader J, Schoel G: Benefits of non-invasive blood pressure monitoring during hypertensive treatment. J Ambul Monit 1990;3:203-214.
17. 17. Prisant LM, Carr AA: Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass. Am J Hypertens 1990;3:81-89.
18. 18. Palatini P, Graniero GR, Canali C, et al, on behalf of the Harvest Study Group. Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension. J Hypertens 1995;13:1776-1800.
19. 19. Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory monitoring. JAMA 1983;249:2793-2798.
20. 20. Verdecchia P, Porcellati C, Schilaci G, et al: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
21. 21. Poggi L, Mallion JM, Renucci JF, et al: Mesure ambulatoire non invasive de la pression arteŕielle. Recommandations du groupe de la mesure de la Société française d'hypertension artérielle (in French). Arch Mal Coeur 1993;86:1137-1142.
22. 22. Staessen J, Fagard R, Lijnen P, et al: The mean and range of the ambulatory blood pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol 1991;67:723-727.
23. 23. Marre M, Claudel JP, Ciret P, et al: Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem 1987;33/2:209-213.
24. 24. Bianchi S, Bigazzi R, Baldari G, et al: Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994;7:23-29.
25. 25. Palatini P, Graniero GR, Mormino P, et al, on behalf of the HARVEST study group: Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST study). Am J Hypertens 1996;9:334-341.
26. 26. Berrut G, Fabbri P, Bouhanick B, et al: Réduction de la baisse nocturne de la pression artérielle chez les sujets diabétiques de type II avec une microalbuminurie (in French). Arch Mal Coeur 1996;89:1041-1044.
27. 27. Equiluz-Bruck S, Schnack C, Kopp HP, et al: Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am J Hypertens 1996;9:1139-1143.
28. 28. Fogari R, Zoppi A, Malamani GD, et al: Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetics. Prevalence of impaired diurnal blood pressure patterns. Am J Hypertens 1993;6:1-7.
29. 29. Berrut G, Hallab M, Bouhanick B, et al: Value of ambulatory blood pressure monitoring in type I (insulin-dependent) diabetic patients with incipient diabetic nephropathy. Am J Hypertens 1994;7:222-227.
30. 30. Schmitz A, Vaeth M: Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Medicine 1988; 5:126-134.
31. 31. Marre M, Girault A, Vasmant D: Prévalence de la microalbuminurie chez les diabétiques de type 2 français suivis par leur médecin généraliste (in French). Diabete Metab 1995;21:34-40.
32. 32. Stiegler H, Standl E, Schulz K, et al: Morbidity, mortality and albuminuria in type 2 diabetic patients: a threeyear prospective study of a random cohort in general practice. Diabetic Med 1992;9:646-653.
33. 33. Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T: The relationship between blood pressure and urinary albumin excretion in the development of microalbuminuria. Diabetes 1990;39:245-249.
34. 34. Cesarone MR, De Sanctis MT, Laurora G, et al: Effects of trandolapril on 24-h ambulatory blood pressure in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 1994;24(suppl 4):S65-S72.
35. 35. Mancia G, De Cesaris R, Fogari R, et al: Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. Am J Cardiol 1992;70:60D-66D.
36. 36. Vaur L, Dutrey-Dupagne C, Boussac J, et al: Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients. J Cardiovasc Pharmacol 1995;26:127-131.
37. 37. Dutrey-Dupagne C, Bobrie G, Vaur L, et al: Demonstration of differences in ACE inhibitors duration of action by self blood pressure measurement. Am J Hypertens 1996;9:146A.
38. 38. Bauduceau B, Vaur L, Rezvani Y, et al: Action du trandolapril sur l'équilibre glycémique et la microalbuminurie chez l'hypertendu diabétique (in French). Ann Cardiol Angeiol 1994;43:84-88.
39. 39. Maki DD, Ma JZ, Louis TA, et al: Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995;155:1073-1080.
40. 40. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
41. 41. Krolewski AS, Laffel LMB, Krolewski M, et al: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1251-1255.